What role does CYP1A2 play in gut health?

CYP1A2 is a cytochrome P450 enzyme primarily expressed in the liver and intestine, known for metabolizing drugs, caffeine, and various dietary compounds. Regarding gut health, mechanistic studies suggest it may play a role in processing dietary xenobiotics and phytochemicals, potentially influencing the gut environment. However, direct evidence linking CYP1A2 activity to specific gut health outcomes—such as microbiome composition, intestinal barrier function, or inflammation—is very limited. Most data come from in vitro or animal models, and human intervention studies are lacking. Furthermore, CYP1A2 activity is highly variable due to genetic polymorphisms (e.g., rs762551) and strong modulation by lifestyle factors like smoking, diet, and medications, making it difficult to isolate its contribution to gut health. While it is plausible that CYP1A2 affects the metabolism of gut-relevant compounds, the current evidence base is weak and does not support a clear, clinically meaningful role. Consumers should be cautious of direct-to-consumer genetic tests that overstate the impact of CYP1A2 variants on gut health without robust human data.